SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-092927
Filing Date
2019-03-29
Accepted
2019-03-29 17:22:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d729799d424b5.htm 424B5 319459
2 GRAPHIC g729799g23n22.jpg GRAPHIC 48791
3 GRAPHIC g729799g39l17.jpg GRAPHIC 23281
  Complete submission text file 0001193125-19-092927.txt   420219
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 424B5 | Act: 33 | File No.: 333-228831 | Film No.: 19717774
SIC: 2834 Pharmaceutical Preparations